CymaBay Therapeutics Inc. (NASDAQ:CBAY) Relative Strength Index (RSI) is 61.51, with weekly volatility at 4.76% and ATR at 0.29. The CBAY stock’s 52-week price range
CymaBay Therapeutics Inc. (NASDAQ:CBAY) has a beta of 1.18. The stock’s Relative Strength Index (RSI) is 56.95, with weekly volatility at 8.49% and ATR at
CymaBay Therapeutics Inc. (NASDAQ:CBAY) shares fell to a low of $4.18 before closing at $4.23. Intraday shares traded counted 0.55 million, which was 37.62% higher
CymaBay Therapeutics Inc. (NASDAQ:CBAY) shares fell to a low of $4.15 before closing at $4.18. Intraday shares traded counted 0.75 million, which was 14.26% higher
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
